Association of SNCA with Parkinson: Replication in the Harvard NeuroDiscovery Center Biomarker Study
Authors:
- 23 September 2011
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 26 (12) , 2283-2286
Abstract
Background: Mutations in the α‐synuclein gene (SNCA) cause autosomal dominant forms of Parkinson's disease, but the substantial risk conferred by this locus to the common sporadic disease has only recently emerged from genome‐wide association studies.Methods: We genotyped a prioritized noncoding variant in SNCA intron 4 in 344 patients with Parkinson's disease and 275 controls from the longitudinal Harvard NeuroDiscovery Center Biomarker Study.Results: The common minor allele of rs2736990 was associated with elevated disease susceptibility (odds ratio, 1.40; P = .0032).Conclusions: This result increases confidence in the notion that in many clinically well‐characterized patients, genetic variation in SNCA contributes to “sporadic” disease. © 2011 Movement Disorder SocietyKeywords
This publication has 7 references indexed in Scilit:
- PGC-1 α, A Potential Therapeutic Target for Early Intervention in Parkinson’s DiseaseScience Translational Medicine, 2010
- Genome-wide association study reveals genetic risk underlying Parkinson's diseaseNature Genetics, 2009
- GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synucleinProceedings of the National Academy of Sciences, 2008
- Multiple regions of α‐synuclein are associated with Parkinson's diseaseAnnals of Neurology, 2005
- α-Synuclein Locus Triplication Causes Parkinson's DiseaseScience, 2003
- The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder serviceBrain, 2002
- Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter systemHuman Molecular Genetics, 2001